Ken Griffin Acutus Medical, Inc. Call Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$0.17 - $0.74 $17 - $74	100 New	100 $0
Q2 2023 Aug 14, 2023	BUY	$0.66 - $1.02 $8,382 - $12,954	12,700 Added 129.59%	22,500 $20,000
Q1 2023 May 15, 2023	SELL	$0.7 - $1.87 $4,410 - $11,781	-6,300 Reduced 39.13%	9,800 $7,000
Q4 2022 Feb 14, 2023	SELL	$0.62 - $1.15 $5,766 - $10,695	-9,300 Reduced 36.61%	16,100 $18,000
Q3 2022 Nov 14, 2022	BUY	$0.76 - $1.66 $836 - $1,826	1,100 Added 4.53%	25,400 $22,000

Ticker AFIB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,370,300
Market Cap $1.99M
Description
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conv...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.